<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04883229</url>
  </required_header>
  <id_info>
    <org_study_id>18-26098</org_study_id>
    <nct_id>NCT04883229</nct_id>
  </id_info>
  <brief_title>tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study</brief_title>
  <official_title>tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Halo Neuroscience</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will test the feasibility of using transcranial direct current stimulation&#xD;
      (tDCS) and speech therapy to treat participants with motor speech disorders caused by&#xD;
      Frontotemporal Lobar Degeneration Pathology including nonfluent variant Primary Progressive&#xD;
      Aphasia, Progressive Supranuclear Palsy, Corticobasal Syndrome, or behavioral variant&#xD;
      Frontotemporal Dementia.&#xD;
&#xD;
      The investigators will deliver transcranial direct current stimulation (tDCS) either in a&#xD;
      clinic setting at the University of California San Francisco, or in patients' homes, via a&#xD;
      consumer tDCS device and videoconferencing. Transcranial direct current stimulation (tDCS) is&#xD;
      a neuromodulation technique that can enhance the benefits of speech therapy treatment.&#xD;
      Participants will receive a dose of tDCS stimulation + speech therapy and a dose of sham tDCS&#xD;
      + speech therapy in a randomized double blind crossover study performed either in the clinic&#xD;
      or at home via videoconferencing. This study can be performed entirely remotely.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in speech intelligibility</measure>
    <time_frame>baseline and immediately after the first block of treatment</time_frame>
    <description>Percent intelligible words, calculated by an SLP scoring each word spoken as intelligible or unintelligible, divided by total number of words spoken, during trained and untrained scripted speech.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in speech intelligibility</measure>
    <time_frame>baseline and immediately after the second block of treatment</time_frame>
    <description>Percent intelligible words, calculated by an SLP scoring each word spoken as intelligible or unintelligible, divided by total number of words spoken, during trained and untrained scripted speech.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in speech intelligibility</measure>
    <time_frame>baseline and three months post treatment</time_frame>
    <description>Percent intelligible words, calculated by an SLP scoring each word spoken as intelligible or unintelligible, divided by total number of words spoken, during trained and untrained scripted speech.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Feasibility of remote use of device</measure>
    <time_frame>Immediately after the second block of treatment</time_frame>
    <description>Acceptability &amp; ease of use of tDCS device from patient's homes. Measured via surveys designed by the investigators. Scores will range from 0 to 100. Higher scores will indicate better acceptability and ease of use.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Nonfluent Aphasia, Progressive</condition>
  <condition>Primary Progressive Nonfluent Aphasia</condition>
  <condition>Primary Progressive Non Fluent Aphasia</condition>
  <condition>Progressive Supranuclear Palsy</condition>
  <condition>Corticobasal Degeneration</condition>
  <condition>Behavioral Variant of Frontotemporal Dementia</condition>
  <arm_group>
    <arm_group_label>tDCS +speech therapy followed by sham tDCS + speech therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>sham tDCS +speech therapy followed by tDCS + speech therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Halo Neuroscience Neurostimulator</intervention_name>
    <description>Experimental: Neurostimulation of 2 milliamps anodal (active) tDCS stimulation for 20 mins during 1 hour speech therapy sessions, 3 times a week for 8 weeks, plus daily homework. Then a washout period of no treatment, followed by a 8 weeks of sham tDCS treatment during 1 hour speech therapy sessions, 3 times a week for 8 weeks, plus daily homework.&#xD;
Active comparator: Experimental: Sham tDCS stimulation for 20 mins during 1 hour speech therapy sessions, 3 times a week for 8 weeks, plus daily homework. Then a washout period of no treatment, followed by a 8 weeks of neurostimulation of 2 milliamps anodal (active) sham tDCS treatment during 1 hour speech therapy sessions, 3 times a week for 8 weeks.</description>
    <arm_group_label>sham tDCS +speech therapy followed by tDCS + speech therapy</arm_group_label>
    <arm_group_label>tDCS +speech therapy followed by sham tDCS + speech therapy</arm_group_label>
    <other_name>Speech therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Mini Mental Status Exam score &gt; 10&#xD;
&#xD;
          -  diagnosis of nfvPPA via Gorno-Tempini 2011 criteria, or a diagnosis of FTLD syndrome&#xD;
             including progressive supranuclear palsy, corticobasal syndrome or behavioral variant&#xD;
             frontotemporal dementia PLUS a motor speech disorder (apraxia of speech and/or&#xD;
             dysarthria)&#xD;
&#xD;
          -  able to give consent&#xD;
&#xD;
          -  right-handed&#xD;
&#xD;
          -  native English speaker&#xD;
&#xD;
          -  having a caregiver who is also able to sign and understand the caregiver's consent&#xD;
             form.&#xD;
&#xD;
        Exclusion Criteria: History of:&#xD;
&#xD;
          -  stroke&#xD;
&#xD;
          -  TBI&#xD;
&#xD;
          -  brain cancer&#xD;
&#xD;
          -  seizures&#xD;
&#xD;
          -  craniotomy, skull surgery or fracture&#xD;
&#xD;
          -  metallic implant in head&#xD;
&#xD;
          -  pacemaker or cardioverter-defibrillator&#xD;
&#xD;
          -  pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Luisa Gorno Tempini, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ariane E Welch, MSLP</last_name>
    <phone>415 353 9135</phone>
    <email>ariane.welch@ucsf.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Ariane E Welch, MSLP</last_name>
      <phone>415-353-9135</phone>
      <email>ariane.welch@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Maria Luisa Gorno Tempini, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Henry ML, Hubbard HI, Grasso SM, Mandelli ML, Wilson SM, Sathishkumar MT, Fridriksson J, Daigle W, Boxer AL, Miller BL, Gorno-Tempini ML. Retraining speech production and fluency in non-fluent/agrammatic primary progressive aphasia. Brain. 2018 Jun 1;141(6):1799-1814. doi: 10.1093/brain/awy101. Erratum in: Brain. 2018 Jul 1;141(7):e57.</citation>
    <PMID>29718131</PMID>
  </reference>
  <reference>
    <citation>Tsapkini K, Frangakis C, Gomez Y, Davis C, Hillis AE. Augmentation of spelling therapy with transcranial direct current stimulation in primary progressive aphasia: Preliminary results and challenges. Aphasiology. 2014;28(8-9):1112-1130.</citation>
    <PMID>26097278</PMID>
  </reference>
  <reference>
    <citation>Cotelli M, Manenti R, Ferrari C, Gobbi E, Macis A, Cappa SF. Effectiveness of language training and non-invasive brain stimulation on oral and written naming performance in Primary Progressive Aphasia: A meta-analysis and systematic review. Neurosci Biobehav Rev. 2020 Jan;108:498-525. doi: 10.1016/j.neubiorev.2019.12.003. Epub 2019 Dec 4.</citation>
    <PMID>31811834</PMID>
  </reference>
  <reference>
    <citation>Wang J, Wu D, Chen Y, Yuan Y, Zhang M. Effects of transcranial direct current stimulation on language improvement and cortical activation in nonfluent variant primary progressive aphasia. Neurosci Lett. 2013 Aug 9;549:29-33. doi: 10.1016/j.neulet.2013.06.019. Epub 2013 Jun 22.</citation>
    <PMID>23800543</PMID>
  </reference>
  <reference>
    <citation>Charvet L, Shaw M, Dobbs B, Frontario A, Sherman K, Bikson M, Datta A, Krupp L, Zeinapour E, Kasschau M. Remotely Supervised Transcranial Direct Current Stimulation Increases the Benefit of At-Home Cognitive Training in Multiple Sclerosis. Neuromodulation. 2018 Jun;21(4):383-389. doi: 10.1111/ner.12583. Epub 2017 Feb 22.</citation>
    <PMID>28225155</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 22, 2020</study_first_submitted>
  <study_first_submitted_qc>May 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2021</study_first_posted>
  <last_update_submitted>May 7, 2021</last_update_submitted>
  <last_update_submitted_qc>May 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Motor Speech Disorders</keyword>
  <keyword>Dysarthria</keyword>
  <keyword>Apraxia of Speech</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aphasia</mesh_term>
    <mesh_term>Supranuclear Palsy, Progressive</mesh_term>
    <mesh_term>Frontotemporal Dementia</mesh_term>
    <mesh_term>Aphasia, Primary Progressive</mesh_term>
    <mesh_term>Pick Disease of the Brain</mesh_term>
    <mesh_term>Communication Disorders</mesh_term>
    <mesh_term>Speech Disorders</mesh_term>
    <mesh_term>Aphasia, Broca</mesh_term>
    <mesh_term>Primary Progressive Nonfluent Aphasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

